Tuesday, January 12, 2021
Brazil trial finds efficacy of Sinovac vaccine at 50.4 percent | Coronavirus pandemic News
A coronavirus vaccine developed by China’s Sinovac Biotech was found to be just 50.4 percent effective at preventing symptomatic infections of COVID-19 in a Brazilian trial, researchers said on Tuesday, barely enough for regulatory approval and well below the rate announced last week. The latest results are a substantial disappointment for Brazil, as the Chinese vaccine is one of two that the 
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Threat actors are exploiting ProxyLogon and ProxyShell exploits in unpatched Microsoft Exchange Servers as part of an ongoing spam campaign
-
You might not need to panic. BroadSoft tells Gizmodo that it locked down its Amazon data (Charter says it was taken down) and hasn’t seen ev...
-
The connection between the Apple Watch and an iPhone is the core of Apple’s wearable experience, and for the first time, the company gave th...
No comments:
Post a Comment